📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: BioVersys

1.1 - Company Overview

BioVersys Logo

BioVersys

Headquarter: Switzerland
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical therapies and novel antibacterial products to combat multidrug-resistant bacterial infections, developing new mode-of-action compounds that switch off drug resistance and restore efficacy of approved antibiotics across Gram-negative, Gram-positive, and Tuberculosis pathogens, with a pipeline advancing through human clinical trials.

Products and services

  • Research & Development of Resistance-Modulating Drugs: Engineers custom-engineered compounds that switch off bacterial drug resistance and restore efficacy of approved antibiotics against MDR pathogens
  • Pipeline of New Mode of Action Compounds: Develops novel-mode-of-action antibacterial products targeting Gram-negative, Gram-positive, and Tuberculosis bacteria to address unmet medical needs in MDR infections
  • Clinical Trials: Conducts clinical-grade human trials for innovative development therapies, following animal proof-of-concept and safety, advancing treatments for serious MDR bacterial infections

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to BioVersys

Diesse Logo

Diesse

HQ: Italy Website
  • Description: Provider of innovative in vitro diagnostic (IVD) systems for the diagnosis of infectious and autoimmune diseases; an Italian developer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Diesse company profile →
Achaogen Logo

Achaogen

HQ: United States Website
  • Description: Provider of biopharmaceutical research and development, discovering and developing broad-spectrum antibiotics to treat multi-drug resistant bacterial infections.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Achaogen company profile →
AN2 Therapeutics Logo

AN2 Therapeutics

HQ: United States Website
  • Description: Provider of boron chemistry–based drug discovery and clinical development for infectious diseases, including epetraborole, an oral therapy in development for chronic non-tuberculous mycobacterial lung disease targeting Mycobacterium avium complex, and conducting clinical trials to obtain regulatory approval for new medications for infectious diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AN2 Therapeutics company profile →
Cempra Logo

Cempra

HQ: United States Website
  • Description: Provider of medicines for the treatment of bacterial infections and chronic illnesses.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cempra company profile →
NanoViricides Logo

NanoViricides

HQ: United States Website
  • Description: Provider of nanomedicine-based antiviral therapeutics, developing broad-spectrum candidates including NV-387 (RSV, smallpox, mpox, influenza A), NV-CoV-2 for COVID-19 and potentially long COVID (Phase 1a/1b), NV-CoV-2-R with remdesivir, and NV-HHV-1 for shingles rash, leveraging the TheraCour platform and the HerpeCide program for herpes infections (cold sores, genital ulcers, keratitis).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NanoViricides company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for BioVersys

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to BioVersys

2.2 - Growth funds investing in similar companies to BioVersys

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for BioVersys

4.2 - Public trading comparable groups for BioVersys

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to BioVersys

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About BioVersys

What does BioVersys do?

BioVersys is a provider of biopharmaceutical therapies and novel antibacterial products to combat multidrug-resistant bacterial infections, developing new mode-of-action compounds that switch off drug resistance and restore efficacy of approved antibiotics across Gram-negative, Gram-positive, and Tuberculosis pathogens, with a pipeline advancing through human clinical trials.

Who are BioVersys's competitors?

BioVersys's competitors and similar companies include Diesse, Achaogen, AN2 Therapeutics, Cempra, and NanoViricides.

Where is BioVersys headquartered?

BioVersys is headquartered in Switzerland.

How many employees does BioVersys have?

BioVersys has 1,000 employees 🔒.

When was BioVersys founded?

BioVersys was founded in 2010 🔒.

What sector and industry vertical is BioVersys in?

BioVersys is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for BioVersys

Who are the top strategic acquirers in BioVersys's sector and industry

Top strategic M&A buyers and acquirers in BioVersys's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for BioVersys?

Top strategic M&A buyers groups and sectors for BioVersys include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in BioVersys's sector and industry vertical

Which are the top PE firms investing in BioVersys's sector and industry vertical?

Top PE firms investing in BioVersys's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in BioVersys's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in BioVersys's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in BioVersys's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to BioVersys include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in BioVersys's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for BioVersys?

The key public trading comparables and valuation benchmarks for BioVersys include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for BioVersys for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for BioVersys with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in BioVersys's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for BioVersys with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in BioVersys's' sector and industry vertical?

Access recent funding rounds and capital raises in BioVersys's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for BioVersys